Activated Notch signaling is required for hepatitis B virus X protein to promote proliferation and survival of human hepatic cells.

[1]  Chunyan Liu,et al.  Hepatitis B viral X protein alters the biological features and expressions of DNA repair enzymes in LO2 cells , 2010, Liver international : official journal of the International Association for the Study of the Liver.

[2]  K. Mayo,et al.  Suppression of Notch signaling in the neonatal mouse ovary decreases primordial follicle formation. , 2009, Endocrinology.

[3]  L. Bolondi,et al.  Aberrant Notch3 and Notch4 expression in human hepatocellular carcinoma , 2007, Liver international : official journal of the International Association for the Study of the Liver.

[4]  H. El‐Serag,et al.  Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. , 2007, Gastroenterology.

[5]  D. Fan,et al.  Expression of Jagged1 and its association with hepatitis B virus X protein in hepatocellular carcinoma. , 2007, Biochemical and biophysical research communications.

[6]  J. Ou,et al.  Hepatitis B virus promotes hepatocarcinogenesis in transgenic mice , 2007, Hepatology.

[7]  S. Bray.  Notch signalling: a simple pathway becomes complex , 2006, Nature Reviews Molecular Cell Biology.

[8]  G. Weinmaster,et al.  A garden of Notch-ly delights , 2006, Development.

[9]  W. Pear,et al.  Impaired notch signaling promotes de novo squamous cell carcinoma formation. , 2006, Cancer research.

[10]  Dr. Chau Tai-Nin,et al.  Hepatocellular Carcinoma and Hepatitis B Virus , 2006 .

[11]  J. Aster,et al.  Notch signaling is a potent inducer of growth arrest and apoptosis in a wide range of B-cell malignancies. , 2005, Blood.

[12]  C. Manetopoulos,et al.  The Notch pathway in cancer: differentiation gone awry. , 2005, European journal of cancer.

[13]  Lan Xiao,et al.  Cannabinoids promote embryonic and adult hippocampus neurogenesis and produce anxiolytic- and antidepressant-like effects. , 2005, The Journal of clinical investigation.

[14]  M. Herlyn,et al.  Activation of Notch1 signaling is required for beta-catenin-mediated human primary melanoma progression. , 2005, The Journal of clinical investigation.

[15]  J. Ferlay,et al.  Global Cancer Statistics, 2002 , 2005, CA: a cancer journal for clinicians.

[16]  D. Ganem,et al.  Hepatitis B virus infection--natural history and clinical consequences. , 2004, The New England journal of medicine.

[17]  K. Raj,et al.  The role of Notch in tumorigenesis: oncogene or tumour suppressor? , 2003, Nature Reviews Cancer.

[18]  John Calvin Reed,et al.  HBXIP functions as a cofactor of survivin in apoptosis suppression , 2003, The EMBO journal.

[19]  H. Stein,et al.  Activated Notch1 signaling promotes tumor cell proliferation and survival in Hodgkin and anaplastic large cell lymphoma. , 2002, Blood.

[20]  G. Hu,et al.  Upstream binding factor up‐regulated in hepatocellular carcinoma is related to the survival and cisplatin‐sensitivity of cancer cells , 2002, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[21]  H. Stein,et al.  Activated Notch 1 signaling promotes tumor cell proliferation and survival in Hodgkin and anaplastic large cell lymphoma , 2002 .

[22]  J. Diao,et al.  X protein of hepatitis B virus modulates cytokine and growth factor related signal transduction pathways during the course of viral infections and hepatocarcinogenesis. , 2001, Cytokine & growth factor reviews.

[23]  Mu-jun Zhao,et al.  Identification of the gene for a novel liver‐related putative tumor suppressor at a high‐frequency loss of heterozygosity region of chromosome 8p23 in human hepatocellular carcinoma , 2000, Hepatology.

[24]  S. Artavanis-Tsakonas,et al.  Notch Signaling : Cell Fate Control and Signal Integration in Development , 1999 .

[25]  J. Sklar,et al.  Notch1-Induced Delay of Human Hematopoietic Progenitor Cell Differentiation Is Associated With Altered Cell Cycle Kinetics , 1999 .

[26]  W. Pear,et al.  Cutting edge: protective effects of notch-1 on TCR-induced apoptosis. , 1999, Journal of immunology.

[27]  A. Jemal,et al.  Global cancer statistics , 2011, CA: a cancer journal for clinicians.

[28]  A. Graessmann,et al.  The Hepatitis B Virus HBx Protein Inhibits Caspase 3 Activity* , 1998, The Journal of Biological Chemistry.

[29]  Y. Yun,et al.  HBx Protein of Hepatitis B Virus Activates Jak1-STAT Signaling* , 1998, The Journal of Biological Chemistry.

[30]  Q. Su,et al.  Expression of hepatitis B virus X protein in HBV‐infected human livers and hepatocellular carcinomas , 1998, Hepatology.

[31]  R. Schneider,et al.  Hepatitis B virus HBx protein deregulates cell cycle checkpoint controls. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[32]  R. Lucito,et al.  The hepatitis B virus HBx protein is a dual specificity cytoplasmic activator of Ras and nuclear activator of transcription factors. , 1995, The EMBO journal.

[33]  Kenji Matsuno,et al.  Notch signaling. , 1995, Science.

[34]  M. Fortini,et al.  Notch signaling. , 1995, Science.

[35]  G. Natoli,et al.  Induction of the DNA-binding activity of c-jun/c-fos heterodimers by the hepatitis B virus transactivator pX , 1994, Molecular and cellular biology.

[36]  R. Lucito,et al.  Hepatitis B virus X protein activates transcription factor NF-kappa B without a requirement for protein kinase C , 1992, Journal of virology.

[37]  G. Jay,et al.  HBx gene of hepatitis B virus induces liver cancer in transgenic mice , 1991, Nature.

[38]  P. Mitchell,et al.  Transactivation by the hepatitis B virus X protein depends on AP-2 and other transcription factors , 1990, Nature.

[39]  D. Ganem,et al.  Transcriptional activation of homologous and heterologous genes by the hepatitis B virus X gene product in cells permissive for viral replication , 1989, Journal of virology.

[40]  Lu-Yu Hwang,et al.  HEPATOCELLULAR CARCINOMA AND HEPATITIS B VIRUS A Prospective Study of 22 707 Men in Taiwan , 1981, The Lancet.